VITURA HEALTH LIMITED (VIT)
Share Price Analysis and Chart
Enter the company code or Name for stock analysis:

VIT - VITURA HEALTH LIMITED
FNArena Sector : NONE
Year End: June
GICS Industry Group : NONE
Debt/EBITDA: 0.48
Index: ALL-ORDS
LAST PRICE | CHANGE +/- | CHANGE % | VOLUME |
---|---|---|---|
$0.38
09 Jun |
0.000 OPEN $0.39 |
0.000 HIGH $0.39 |
116,365 LOW $0.38 |
TARGET | |||||
|
FNARENA'S MARKET CONSENSUS FORECASTS
Title | FY21 Actual |
FY22 Actual |
FY23 Forecast |
FY24 Forecast |
---|---|---|---|---|
EPS (cps) | xxx | 1.3 | 2.9 | xxx |
DPS (cps) | xxx | 1.0 | 1.0 | xxx |
EPS Growth | xxx | N/A | 100.0% | xxx |
DPS Growth | xxx | N/A | 0.0% | xxx |
PE Ratio | xxx | N/A | 13.1 | xxx |
Dividend Yield | xxx | N/A | 2.6% | xxx |
Div Pay Ratio(%) | xxx | 80.0% | 34.5% | xxx |
DIVIDEND YIELD CALCULATOR
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2023 FactSet UK Limited. All rights reserved
Title | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
EPS Basic | xxx | xxx | xxx | xxx | 1.3 |
DPS All | xxx | xxx | xxx | xxx | 1.0 |
Sales/Revenue | xxx | xxx | xxx | xxx | 67.0 M |
Book Value Per Share | xxx | xxx | xxx | xxx | 4.7 |
Net Operating Cash Flow | xxx | xxx | xxx | xxx | 13.5 M |
Net Profit Margin | xxx | xxx | xxx | xxx | 9.03 % |
EPS Basic
DPS All
Sales/Revenue
Book Value Per Share
Net Operating Cash Flow
Net Profit Margin
Title | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
Return on Capital Employed | xxx | xxx | xxx | xxx | 34.17 % |
Return on Invested Capital | xxx | xxx | xxx | xxx | 30.08 % |
Return on Assets | xxx | xxx | xxx | xxx | 21.78 % |
Return on Equity | xxx | xxx | xxx | xxx | 34.17 % |
Return on Total Capital | xxx | xxx | xxx | xxx | 46.45 % |
Free Cash Flow ex dividends | xxx | xxx | xxx | xxx | 13.1 M |
Return on Capital Employed
Return on Invested Capital
Return on Assets
Return on Equity
Return on Total Capital
Free Cash Flow ex dividends
Title | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
Short-Term Debt | xxx | xxx | xxx | xxx | 0 M |
Long Term Debt | xxx | xxx | xxx | xxx | 5 M |
Total Debt | xxx | xxx | xxx | xxx | 5 M |
Goodwill - Gross | xxx | xxx | xxx | xxx | - |
Cash & Equivalents - Generic | xxx | xxx | xxx | xxx | 16 M |
Price To Book Value | xxx | xxx | xxx | xxx | 5.27 |
Short-Term Debt
Long Term Debt
Total Debt
Goodwill - Gross
Cash & Equivalents - Generic
Price To Book Value
Title | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
Capex | xxx | xxx | xxx | xxx | 0.4 M |
Capex % of Sales | xxx | xxx | xxx | xxx | 0.56 % |
Cost of Goods Sold | xxx | xxx | xxx | xxx | 54 M |
Selling, General & Admin. Exp & Other | xxx | xxx | xxx | xxx | 3 M |
Research & Development | xxx | xxx | xxx | xxx | - |
Investments - Total | xxx | xxx | xxx | xxx | - |
Capex
Capex % of Sales
Cost of Goods Sold
Selling, General & Admin. Exp & Other
Research & Development
Investments - Total
EXPERT VIEWS
Display All Commentary
Sentiment Indicator
1.0
No. Of Recommendations
1
VIT STOCK CHART